tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Intensity Therapeutics Inc

INTS
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
4.150USD
+0.140+3.49%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
10.54M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Intensity Therapeutics Inc

4.150
+0.140+3.49%
๊ฐœ์š”
๊ธˆ์œต
ํ† ๋ก 
๋ถ„์„
ํšŒ์‚ฌ
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

๊ฐœ์š”

๊ธˆ์œต

ํ† ๋ก 

๋ถ„์„

ํšŒ์‚ฌ

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

INTS ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Intensity Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Intensity Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 7, 2026
EPS / ์˜ˆ์ƒ
-0.96/-1.09
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00
์˜ˆ์ •๋œ ์‹ค์  ๋ฐœํ‘œ ์ผ์ • ๋ณด๊ธฐ >>
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
--
--
EPS(YoY)
-214.00
-631.77%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/07/31
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-335.45%-0.96
-492.85%-1.31
-509.58%-1.55
62.91%-0.13
34.30%-0.22
4.52%-0.22
-49.75%-0.25
5.50%-0.36
-229.07%-0.34
-100.63%-0.23
---0.17
---0.38
---0.10
---0.12
----
----
----
----
----
----
์ˆœ์ด์ต
27.28%-2.43M
4.09%-3.05M
23.97%-2.67M
48.96%-2.54M
27.29%-3.35M
-0.29%-3.18M
-50.79%-3.51M
1.07%-4.97M
-244.41%-4.60M
-109.99%-3.17M
-31.26%-2.33M
-160.68%-5.03M
43.59%-1.34M
37.09%-1.51M
16.46%-1.77M
-1.94%-1.93M
-60.20%-2.37M
-46.90%-2.40M
-36.68%-2.12M
---1.89M
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
----
-100.00%0.00%
--0.00%
--0.00%
--470.59%
--247.48%
----
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์˜์—… ์ด์ต
25.57%-2.53M
1.97%-3.14M
23.45%-2.73M
46.64%-2.71M
28.44%-3.39M
4.46%-3.20M
-43.34%-3.57M
-315.15%-5.07M
-278.19%-4.74M
-127.48%-3.35M
-40.88%-2.49M
36.73%-1.22M
47.60%-1.25M
38.85%-1.47M
17.31%-1.77M
1.78%-1.93M
-59.46%-2.39M
-45.43%-2.41M
-29.91%-2.14M
---1.96M
์ˆœ์ด์ต
27.28%-2.43M
4.09%-3.05M
23.97%-2.67M
48.96%-2.54M
27.29%-3.35M
-0.29%-3.18M
-50.79%-3.51M
1.07%-4.97M
-244.41%-4.60M
-109.99%-3.17M
-31.26%-2.33M
-160.68%-5.03M
43.59%-1.34M
37.09%-1.51M
16.46%-1.77M
-1.94%-1.93M
-60.20%-2.37M
-46.90%-2.40M
-36.68%-2.12M
---1.89M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
560.57%10.91M
277.91%12.71M
116.16%8.19M
-59.17%3.04M
-85.22%1.65M
-78.25%3.36M
-77.23%3.79M
-58.80%7.44M
1398.92%11.17M
966.24%15.46M
1850.56%16.63M
862.13%18.06M
-77.21%745.14K
-69.34%1.45M
-88.92%852.82K
-73.86%1.88M
-60.44%3.27M
-50.87%4.73M
-32.19%7.70M
-27.28%7.18M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-14.72%2.24M
22.28%2.15M
-1.77%2.28M
-32.46%2.16M
4.37%2.63M
-55.67%1.75M
220.04%2.32M
4.76%3.20M
-63.37%2.52M
-41.94%3.96M
-86.55%723.97K
-34.51%3.06M
57.44%6.88M
83.26%6.82M
21.76%5.38M
125.66%4.67M
189.36%4.37M
176.43%3.72M
184.99%4.42M
51.63%2.07M
์ด ์ž์‚ฐ
301.01%12.29M
194.81%14.10M
83.87%9.59M
-48.77%4.44M
-75.30%3.06M
-72.34%4.78M
-69.00%5.21M
-52.42%8.67M
1204.06%12.41M
884.26%17.30M
1295.41%16.82M
701.46%18.23M
-74.46%951.49K
-66.31%1.76M
-85.14%1.21M
-70.15%2.27M
-58.12%3.72M
-48.61%5.22M
-29.86%8.11M
-24.63%7.62M
๋ถ€์ฑ„ ์ด๊ณ„
-15.34%2.31M
19.30%2.23M
-2.92%2.36M
-32.12%2.26M
1.68%2.73M
-54.88%1.86M
168.99%2.43M
7.55%3.33M
-61.15%2.69M
-39.70%4.13M
-83.30%904.86K
-34.92%3.09M
53.61%6.91M
75.74%6.85M
16.60%5.42M
103.01%4.75M
146.31%4.50M
128.32%3.90M
189.87%4.65M
60.45%2.34M
์ž๋ณธ ์ด๊ณ„
2887.72%9.98M
306.99%11.88M
159.88%7.22M
-59.14%2.18M
-96.56%334.00K
-77.83%2.92M
-82.53%2.78M
-64.68%5.34M
263.06%9.72M
358.22%13.16M
477.54%15.91M
710.18%15.13M
-668.28%-5.96M
-487.35%-5.10M
-221.75%-4.21M
-147.00%-2.48M
-110.98%-776.05K
-84.41%1.32M
-65.24%3.46M
-38.99%5.28M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
8.20%-1.83M
10.01%-2.40M
39.90%-2.39M
41.72%-2.46M
54.44%-1.99M
-181.68%-2.67M
22.40%-3.97M
-1663.82%-4.21M
-384.91%-4.37M
42.05%-947.17K
-399.04%-5.12M
82.08%-238.91K
39.32%-900.37K
43.03%-1.63M
31.53%-1.03M
-6.11%-1.33M
-23.29%-1.48M
-66.88%-2.87M
-33.07%-1.50M
---1.26M
์ˆœํˆฌ์ž
----
--0.00
-100.00%0.00
100.00%0.00
-100.00%0.00
-100.00%0.00
135.05%3.10M
---6.00K
--3.26M
--2.82M
---8.84M
----
----
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
100.00%0.00
--0.00
์ˆœ์žฌ๋ฌดํ™œ๋™
-54.27%150.00K
193.01%7.25M
1652.54%7.24M
124666.67%3.74M
4000.00%328.00K
20461.84%2.48M
-97.99%413.00K
101.24%3.00K
-96.10%8.00K
-100.54%-12.16K
--20.52M
-1852.52%-241.83K
1585.61%205.00K
--2.25M
-100.00%0.00
--13.80K
---13.80K
100.00%0.00
-21.16%2.05M
--0.00

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Intensity Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Intensity Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 12.71M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 277.91์ž…๋‹ˆ๋‹ค.

Intensity Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Intensity Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Intensity Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 14.10M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 194.81์ž…๋‹ˆ๋‹ค.

Intensity Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Intensity Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Intensity Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 2.23M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 19.30์ž…๋‹ˆ๋‹ค.

Intensity Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Intensity Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Intensity Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 11.88M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 306.99์ž…๋‹ˆ๋‹ค.

Intensity Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Intensity Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Intensity Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -11.97M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 27.81์ž…๋‹ˆ๋‹ค.

Intensity Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Intensity Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Intensity Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 18.56M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 540.14์ž…๋‹ˆ๋‹ค.

Intensity Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Intensity Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -214.00์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -631.77์ž…๋‹ˆ๋‹ค.

Intensity Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Intensity Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -11.61M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 28.66์ž…๋‹ˆ๋‹ค.

Intensity Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Intensity Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -156.90์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 22.46์ž…๋‹ˆ๋‹ค.

Intensity Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Intensity Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -122.92์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 16.59์ž…๋‹ˆ๋‹ค.

Intensity Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Intensity Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -11.97M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 27.81์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ